Hem › Non-Hodgkins lymfom › Indiana
Kliniska studier för Non-Hodgkins lymfom i Indiana
10 studier för Non-Hodgkins lymfom söker deltagare vid platser i Indiana.
Städer i Indiana
Officiell studietext (engelska)
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 101, Fort Wayne
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07582432TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT02693535Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Indiana Blood and Marrow Transplantation, Indianapolis
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 aug. 2026 · NCT05826535Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Riley Hospital for Children, Indianapolis
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Indiana University/Riley Hospital for Children, Indianapolis
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Community Health Network, Indianapolis
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juni 2026 · NCT04068597Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Woodland Cancer Care Center, Michigan City
- Reid Health, Richmond
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 10 feb. 2026 · NCT06484920AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- American Oncology Partners, Fort Wayne
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 10 dec. 2025 · NCT05602363Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Goshen Center for Cancer Care, Goshen
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 aug. 2022 · NCT04502394Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.